Tranche Update on Dongwha Pharm Co.,Ltd.'s Equity Buyback Plan announced on January 30, 2015.
April 23, 2015
Share
From April 1, 2015 to April 22, 2015, the company has repurchased 128,504 shares, representing 0.46% for KRW 1,058.04 million. With this, the company has completed the repurchase of 320,000 shares, representing 1.15% for KRW 2,349.54 million under the buyback announced on January 30, 2015.
DONGWHA PHARM.CO., LTD is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products consist of ethical drugs, including digestive system remedies, antibiotics, cardiovascular and metabolic disease treatments, non steroidal anti-inflammatory drugs, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies and urinary system remedies, and over-the-counter (OTC) drugs, including cold remedies, dental remedies, dermatological remedies, hepatic protectors, nutrients, tonics, topical analgesics, anti-smoking agents and others. It also provides medicine raw materials, health food and drinks, as well as cosmetics. The Company distributes its products within domestic market and to overseas markets.
DONGWHA PHARM.CO.,LTD 
